M L 22 (Lisinopril 2.5 mg)

Pill imprint M L 22 has been identified as Lisinopril 2.5 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; heart failure (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M L 22

Lisinopril 2.5 mg M L 22
Lisinopril 2.5 mg M L 22 Front
Lisinopril 2.5 mg M L 22 Back
Lisinopril 2.5 mg M L 22
Lisinopril 2.5 mg M L 22
Lisinopril
Imprint:
M
L 22
Strength:
2.5 mg
Color:
Blue
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2072
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
povidone
corn starch
sodium lauryl sulfate
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0256 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)